By Abigail Townsend
Date: Thursday 23 Apr 2026
(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance on Thursday, despite a rise in costs following the outbreak of war in the Middle East.
By Abigail Townsend
Date: Thursday 26 Feb 2026
(Sharecast News) - Shares in Hikma Pharmaceuticals tumbled on Thursday, after the generics drugmaker withdrew its medium-term guidance and adopted a cautious outlook for the current year.
By Michele Maatouk
Date: Wednesday 04 Feb 2026
(Sharecast News) - Brookfield confirmed on Wednesday that it does not plan on making an offer for Hikma Pharmaceuticals.
| Currency | UK Pounds |
| Share Price | 1,477.00p |
| Change Today | 22.00p |
| % Change | 1.51 % |
| 52 Week High | 2,148.00 |
| 52 Week Low | 1,191.00 |
| Volume | 865,432 |
| Shares Issued | 215.50m |
| Market Cap | £3,182.90m |
| Beta | 0.00 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 19-Mar-26 | 14-Aug-25 |
| Paid | 30-Apr-26 | 18-Sep-25 |
| Amount | 48.00¢ | 36.00¢ |
| Time | Volume / Share Price |
| 16:22 | 0 @ 1,477.00p |
| 16:22 | 215 @ 1,477.00p |
| 16:22 | 200 @ 1,477.00p |
| 16:22 | 75 @ 1,477.00p |
| 16:21 | 233 @ 1,476.00p |
| CEO | Said Darwazah |
| Chair | Victoria Hull |
You are here: research